Critical success factors of business process management:investigating the coverage of business process (management) maturity models

Business Process Management (BPM) aims to improve the quality of business processes by consolidating the concepts of modelling, reengineering, automation, management, and innovation. Tailoring multi-faceted BPM to specific contexts of organizations on the ground of fast-growing information technology is the challenge of the current decade. A considerable number of critical success factors (CSFs) for BPM has been proposed by various studies in the scientific literature to provide insight into the process of achieving BPM. However, only few of these studies propose guidelines/practices for addressing the CSFs. This study is intended to provide a state-of-the-art of CSFs of BPM by a systematic review of scientific literature and to investigate content coverage of business process maturity models as a potential enabler of realization of these CSFs. We searched the studies between the years 2000 and 2015 in established digital libraries and identified 14 CSF categories from 18 studies out of 242 studies retrieved initially. Following that, we searched for evidence on the existence of each CSF category in five maturity models, namely Business Process Management Capability Framework (BPM-CF), Business Process Orientation Maturity Model (BPO-MM), Business Process Orientation Maturity Framework (BPO-MF), Business Process Maturity Model (OMG-BPMM), and Process and Enterprise Maturity Model (PEMM). The findings from our investigation show that, despite the variance in degree of coverage of CSF categories by selected BPMMs, maturity models stand as a promising reference for organizations to start their BPM efforts.\u3cbr/\u3

Synchronous Appearance of a High-Grade Neuroendocrine Carcinoma of the Ampulla Vater and Sigmoid Colon Adenocarcinoma

Neuroendocrine carcinoma is a relatively rare tumor and its coexistence with other primary cancers is very exceptional. We present a case of a 63-year-old woman with biliary obstruction due to a high-grade neuroendocrine carcinoma located in ampulla of Vater who was found to have a synchronous sigmoid colon adenocarcinoma while undergoing staging laparotomy and pancreas head resection. Medical history was significant only for basal cell skin cancer. Immunohistochemical examination revealed the concurrence of histologically proved neuroendocrine carcinoma (chromogranin A, synaptophysin, and CD56 were positive) and Stage II (T3, N0, and M0) according to the TNM staging classification of colorectal cancer. The coexistence of neuroendocrine tumors with either synchronous or metachronous unrelated cancer is increasingly recognized. The patients with neuroendocrine carcinoma should be evaluated for secondary primary malignancies

Hastalar İçin Her Yönüyle Kemoterapi Süreci

Kemoterapi El Kitabı isimli kitabı yeni düzenleme ile "Hastalar İçin Her Yönüyle Kemoterapi Süreci" ismiyle yayınladık .Bu kitapta hastalar için kemoterapi sürecinde yapması gerekenler, genel&nbsp; kavramlar üzerinde duruldu.</p

Case Report of Osler-Weber-Rendu Syndrome with Incidentally Detected Ipsilateral Renal Adnexal Agenesis

Osler-Weber-Rendu Syndrome, also known as hereditary hemorrhagic telangiectasia, is an autosomal dominant disease characterized by the presence of vascular telangiectasias in the skin and mucosa. Epistaxis can occur due to telangiectasias in the nasal mucosa and oral cavity. Diffuse arteriovenous malformations may occur in the lung, liver, and brain. Histopathology shows superficially located thin-walled vascular structures.In this case report, we present a multiparous patient in her 50s who was diagnosed with Osler-Weber-Rendu syndrome during examination due to complaints of recurrent nosebleeds and widespread telangiectasia in the skin/mucosa. In addition, ipsilateral renal-adnexal agenesis and a 3 cm intrahepatic mass were incidentally detected on cross-sectional imaging. A biopsy was taken from the mass in the liver and pathological examination revealed follicular nodular hyperplasia. Her kidney function test is within normal limits and she is multiparous. Following all examinations, symptomatic treatment for nosebleeds and iron replacement therapy were started.</p

A Case Report of Synchronous Lung Adenocarcinoma and Systemic Mastocytosis

Systemic mastocytosis(SM) is an extremely rare disease and is characterized by clonal proliferation of mast cells in anypart of the body. SM patients are prone to developing cancer. Although the relationship between lung adenocarcinomaand SM is unclear, they share similar mutations. A female patient in her 40s presented with complaints of shoulder painand unexpected weight. Later, the patient was diagnosed with lung adenocarcinoma. Additionally, systemicmastocytosis was detected while investigating her B symptoms and anemia. Induction chemotherapy with carboplatinand paclitaxel was decided as initial treatment. She did not respond to 3 cycles of this chemotherapy regimen.Radiotherapy with etoposide and cisplatin was applied as second-line treatment. Although the size of the lungadenocarcinoma was stable, her anemia, shoulder pain, B symptoms, and cachexia improved after second-line treatment.We present a case of synchronous lung adenocarcinoma and systemic mastocytosis presenting with B symptoms andshoulder pain.Keywords: Anemia, Lung Carcinoma, Systemic Mastocytosis, Synchronous.</p